To include your compound in the COVID-19 Resource Center, submit it here.

Vicarius raises $21.8M in series A

Commercialization company Vicarius Pharma AG (Kuessnacht, Switzerland) raised $21.8 million

Read the full 107 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE